Olanzapine treatment in patients with typical and atypical neuroleptic- associated agranulocytosis

B. Finkel; A. Lerner; I. Oyffe; D. Rudinski; M. Sigal; A. Weizman

doi:10.1097/00004850-199805000-00007

Olanzapine treatment in patients with typical and atypical neuroleptic- associated agranulocytosis

B. Finkel^*, A. Lerner, I. Oyffe, D. Rudinski, M. Sigal, A. Weizman

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Two cases are reported of patients who developed agranulocytosis after treatment with typical and atypical antipsychotics. The patients were successfully treated with olanzapine. We suggest the consideration of olanzapine as a safer treatment in patients who require immediate continuation of antipsychotic medication and have a prior history of classic and atypical neuroleptic-induced agranulocytosis.

Original language	English
Pages (from-to)	133-135
Number of pages	3
Journal	International Clinical Psychopharmacology
Volume	13
Issue number	3
DOIs	https://doi.org/10.1097/00004850-199805000-00007
State	Published - 1998

Keywords

Agranulocytosis
Classic antipsychotics
Clozapine
Olanzapine
Risperidone

Access to Document

10.1097/00004850-199805000-00007

Cite this

@article{063faacec20647fd88dd507ec6b9ab9b,

title = "Olanzapine treatment in patients with typical and atypical neuroleptic- associated agranulocytosis",

abstract = "Two cases are reported of patients who developed agranulocytosis after treatment with typical and atypical antipsychotics. The patients were successfully treated with olanzapine. We suggest the consideration of olanzapine as a safer treatment in patients who require immediate continuation of antipsychotic medication and have a prior history of classic and atypical neuroleptic-induced agranulocytosis.",

keywords = "Agranulocytosis, Classic antipsychotics, Clozapine, Olanzapine, Risperidone",

author = "B. Finkel and A. Lerner and I. Oyffe and D. Rudinski and M. Sigal and A. Weizman",

year = "1998",

doi = "10.1097/00004850-199805000-00007",

language = "אנגלית",

volume = "13",

pages = "133--135",

journal = "International Clinical Psychopharmacology",

issn = "0268-1315",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "3",

}

TY - JOUR

T1 - Olanzapine treatment in patients with typical and atypical neuroleptic- associated agranulocytosis

AU - Finkel, B.

AU - Lerner, A.

AU - Oyffe, I.

AU - Rudinski, D.

AU - Sigal, M.

AU - Weizman, A.

PY - 1998

Y1 - 1998

N2 - Two cases are reported of patients who developed agranulocytosis after treatment with typical and atypical antipsychotics. The patients were successfully treated with olanzapine. We suggest the consideration of olanzapine as a safer treatment in patients who require immediate continuation of antipsychotic medication and have a prior history of classic and atypical neuroleptic-induced agranulocytosis.

AB - Two cases are reported of patients who developed agranulocytosis after treatment with typical and atypical antipsychotics. The patients were successfully treated with olanzapine. We suggest the consideration of olanzapine as a safer treatment in patients who require immediate continuation of antipsychotic medication and have a prior history of classic and atypical neuroleptic-induced agranulocytosis.

KW - Agranulocytosis

KW - Classic antipsychotics

KW - Clozapine

KW - Olanzapine

KW - Risperidone

UR - http://www.scopus.com/inward/record.url?scp=0031820945&partnerID=8YFLogxK

U2 - 10.1097/00004850-199805000-00007

DO - 10.1097/00004850-199805000-00007

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:0031820945

SN - 0268-1315

VL - 13

SP - 133

EP - 135

JO - International Clinical Psychopharmacology

JF - International Clinical Psychopharmacology

IS - 3

ER -

Olanzapine treatment in patients with typical and atypical neuroleptic- associated agranulocytosis

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this